Unknown

Dataset Information

0

Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands.


ABSTRACT: Accurate, consistent and reproducible grading by pathologists is of key-importance for identification of individual patients with invasive breast cancer (IBC) that will or will not benefit from adjuvant systemic treatment. We studied the laboratory-specific grading variation using nationwide real-life data to create insight and awareness in grading variation. Synoptic pathology reports of all IBC resection-specimens, obtained between 2013 and 2016, were retrieved from the nationwide Dutch Pathology Registry (PALGA). Absolute differences in laboratory-proportions of Grades I-III were compared to the national reference. Multivariable logistic regression provided laboratory-specific odds ratios (ORs) for high- vs. low-grade IBC. 33,792 IBC pathology reports of 33,043 patients from 39 laboratories were included, of which 28.1% were reported as Grade I (range between laboratories 16.3-43.3%), 47.6% as Grade II (38.4-57.8%), and 24.3% as Grade III (15.5-34.3%). Based on national guidelines, the indication for adjuvant chemotherapy was dependent on histologic grade in 29.9% of patients. After case-mix correction, 20 laboratories (51.3%) showed a significantly deviant OR. Significant grading differences were also observed among pathologists within laboratories. In this cohort of 33,043 breast cancer patients, we observed substantial inter- and intra-laboratory variation in histologic grading. It can be anticipated that this has influenced outcome including exposure to unnecessary toxicity, since choice of adjuvant chemotherapy was dependent on grade in nearly a third of patients. Better standardization and training seems warranted.

SUBMITTER: van Dooijeweert C 

PROVIDER: S-EPMC6916412 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands.

van Dooijeweert Carmen C   van Diest Paul J PJ   Willems Stefan M SM   Kuijpers Chantal C H J CCHJ   van der Wall Elsken E   Overbeek Lucy I H LIH   Deckers Ivette A G IAG  

International journal of cancer 20190429 3


Accurate, consistent and reproducible grading by pathologists is of key-importance for identification of individual patients with invasive breast cancer (IBC) that will or will not benefit from adjuvant systemic treatment. We studied the laboratory-specific grading variation using nationwide real-life data to create insight and awareness in grading variation. Synoptic pathology reports of all IBC resection-specimens, obtained between 2013 and 2016, were retrieved from the nationwide Dutch Pathol  ...[more]

Similar Datasets

| S-EPMC6422994 | biostudies-literature
| S-EPMC8582481 | biostudies-literature
| S-EPMC6501876 | biostudies-other
2015-03-07 | GSE66622 | GEO
| S-EPMC4404591 | biostudies-literature
2015-03-07 | E-GEOD-66622 | biostudies-arrayexpress
| S-EPMC7216330 | biostudies-literature
| S-EPMC6637972 | biostudies-literature
| S-EPMC8278960 | biostudies-literature
| S-EPMC9393406 | biostudies-literature